{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:13:26Z","timestamp":1789787606306,"version":"4.0.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2024YFFK0382"],"award-info":[{"award-number":["2024YFFK0382"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.colsurfb.2026.115586","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:03:10Z","timestamp":1772524990000},"page":"115586","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Heterogeneous inorganic nanomedicine delivery system loaded with anlotinib for enhanced treatment of non-small cell lung cancer (NSCLC)"],"prefix":"10.1016","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0654-6031","authenticated-orcid":false,"given":"Minzhang","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengni","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangzhou","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.colsurfb.2026.115586_bib1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/cncr.35128","article-title":"Lung cancer statistics, 2023","volume":"130","author":"Kratzer","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.colsurfb.2026.115586_bib2","doi-asserted-by":"crossref","first-page":"l1725","DOI":"10.1136\/bmj.l1725","article-title":"Lung cancer","volume":"365","author":"Neal","year":"2019","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115586_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1513\/AnnalsATS.201907-556CME","article-title":"Disparities in lung cancer screening: a review","volume":"17","author":"Haddad","year":"2020","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.colsurfb.2026.115586_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2019.10.009","article-title":"Epidemiology of lung cancer and lung cancer screening programs in China and the United States","volume":"468","author":"Yang","year":"2020","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00408-019-00294-5","article-title":"Lung cancer in the young","volume":"198","author":"Galvez-Nino","year":"2020","journal-title":"Lung"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115586_bib6","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/cac2.12359","article-title":"Non-small cell lung cancer in China","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115586_bib7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.5858\/arpa.2011-0055-LE","article-title":"Revolution in lung cancer: new challenges for the surgical pathologist","volume":"136","author":"Orenstein","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115586_bib8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1183\/13993003.01490-2015","article-title":"Optimising treatment for post-operative lung cancer recurrence","volume":"47","author":"Subotic","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115586_bib9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00262-024-03800-8","article-title":"Increasing monocytes after lung cancer surgery triggers the outgrowth of distant metastases, causing recurrence","volume":"73","author":"Kawaguchi","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/1759-7714.12543","article-title":"Remarkable response of nivolumab-refractory lung cancer to salvage chemotherapy","volume":"9","author":"Ogawara","year":"2018","journal-title":"Thorac. Cancer"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115586_bib11","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/annonc\/mdw271","article-title":"Chemotherapy remains an essential element of personalized care for persons with lung cancers","volume":"27","author":"Hellmann","year":"2016","journal-title":"Ann. Oncol."},{"issue":"16","key":"10.1016\/j.colsurfb.2026.115586_bib12","doi-asserted-by":"crossref","first-page":"e20508","DOI":"10.1200\/JCO.2022.40.16_suppl.e20508","article-title":"Clinical outcomes in immunotherapy and chemotherapy in minority populations with non-small cell lung cancer (NSCLC)","volume":"40","author":"Shin","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115586_bib13","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s40265-018-0939-x","article-title":"Anlotinib: first global approval","volume":"78","author":"Syed","year":"2018","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-024-01982-2","article-title":"Benmelstobart plus anlotinib in patients with EGFR-positive advanced NSCLC after failure of EGFR TKIs therapy: a phase I\/II study","volume":"9","author":"Shi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/jamaoncol.2018.5526","article-title":"Anlotinib for refractory advanced non\u2013small cell lung cancer in China","volume":"5","author":"Chen","year":"2019","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/neuonc\/noaa236","article-title":"The efficacy of anlotinib instead of glucocorticoids for edema induced by brain metastases in NSCLC patients with anti-PD1\/PDL-1 immunotherapy","volume":"23","author":"Zhuang","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.colsurfb.2026.115586_bib17","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2147\/OTT.S364566","article-title":"FGFR2-ERC1: a subtype of FGFR2 oncogenic fusion variant in lung adenocarcinoma and the response to anlotinib","volume":"15","author":"Hong","year":"2022","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-018-0664-7","article-title":"Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development","volume":"11","author":"Shen","year":"2018","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115586_bib19","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/s41401-020-0421-7","article-title":"Chromatin accessibility analysis reveals that TFAP2A promotes angiogenesis in acquired resistance to anlotinib in lung cancer cells","volume":"41","author":"Zhang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"16","key":"10.1016\/j.colsurfb.2026.115586_bib20","doi-asserted-by":"crossref","first-page":"e17542","DOI":"10.1200\/JCO.2022.40.16_suppl.e17542","article-title":"Anlotinib suppresses growth and metastasis through MAPK signaling pathway in cisplatin-resistant ovarian cancer cells","volume":"40","author":"Ji","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115586_bib21","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/aps.2017.199","article-title":"Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species","volume":"39","author":"Zhong","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.colsurfb.2026.115586_bib22","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.2147\/DDDT.S426898","article-title":"Research progress on mechanism and management of adverse drug reactions of anlotinib","volume":"17","author":"Li","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.colsurfb.2026.115586_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.548300","article-title":"Longitudinal pharmacometabonomics for predicting malignant tumor patient responses to anlotinib therapy: phenotype, efficacy, and toxicity","volume":"10","author":"Hu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.colsurfb.2026.115586_bib24","article-title":"Anlotinib induced type 1 diabetes: a case report","volume":"15","author":"Chen","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.colsurfb.2026.115586_bib25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jconrel.2022.10.046","article-title":"Responsive shape-shifting nanoarchitectonics and its application in tumor diagnosis and therapy","volume":"352","author":"Shao","year":"2022","journal-title":"J. Control. Release"},{"issue":"21","key":"10.1016\/j.colsurfb.2026.115586_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202504672","article-title":"Precision-guided stealth missiles in biomedicine: biological carrier-mediated nanomedicine hitchhiking strategy","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.colsurfb.2026.115586_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.radphyschem.2022.110087","article-title":"EPR study of silicon nitride (Si3N4) nanoparticles exposed to neutron irradiation","volume":"195","author":"Huseynov","year":"2022","journal-title":"Radiat. Phys. Chem."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib28","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1038\/s41467-023-40683-2","article-title":"Embedded nano spin sensor for in situ probing of gas adsorption inside porous organic frameworks","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/acsanm.4c05799","article-title":"Ammonium sulfate gradient-prepared anlotinib-loaded liposomes for potent tumor therapy with decreased side effect","volume":"8","author":"Sun","year":"2025","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.colsurfb.2026.115586_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125788","article-title":"Vicious-cycle-breaking antiangiogenic nano-delivery systems potentiate and simplify the tumor vascular normalization strategy","volume":"681","author":"Qi","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115586_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1568009623666230810121918","article-title":"A pilot study of anlotinib as a combination treatment in advanced nasopharyngeal carcinoma","volume":"24","author":"Zhou","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.colsurfb.2026.115586_bib32","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jconrel.2020.01.048","article-title":"Mesoporous polydopamine carrying sorafenib and SPIO nanoparticles for MRI-guided ferroptosis cancer therapy","volume":"320","author":"Guan","year":"2020","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115586_bib33","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1007\/s12274-020-2839-0","article-title":"A novel clustered SPIO nanoplatform with enhanced magnetic resonance T2 relaxation rate for micro-tumor detection and photothermal synergistic therapy","volume":"13","author":"Lu","year":"2020","journal-title":"Nano Res"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1468678319825689","article-title":"Mechanistic and energetic studies of superparamagnetic iron oxide nanoparticles as a cyclophosphamide anticancer drug nanocarrier: a quantum mechanical approach","volume":"44","author":"Mozayyeni","year":"2019","journal-title":"Prog. React. Kinet. Mech."},{"key":"10.1016\/j.colsurfb.2026.115586_bib35","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.2147\/IJN.S321984","article-title":"Superparamagnetic iron oxide nanoparticles: cytotoxicity, metabolism, and cellular behavior in biomedicine applications","volume":"16","author":"Wei","year":"2021","journal-title":"Int. J. Nanomed."},{"issue":"34","key":"10.1016\/j.colsurfb.2026.115586_bib36","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.1016\/j.biomaterials.2010.08.039","article-title":"Multifunctional SPIO\/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging","volume":"31","author":"Yang","year":"2010","journal-title":"Biomaterials"},{"issue":"22","key":"10.1016\/j.colsurfb.2026.115586_bib37","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1039\/C7TB00040E","article-title":"Curcumin\/sunitinib co-loaded BSA-stabilized SPIOs for synergistic combination therapy for breast cancer","volume":"5","author":"Chen","year":"2017","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib38","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.1038\/s41467-022-35655-x","article-title":"A pH-responsive T1-T2 dual-modal MRI contrast agent for cancer imaging","volume":"13","author":"Lu","year":"2022","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.colsurfb.2026.115586_bib39","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1016\/j.biomaterials.2014.04.052","article-title":"Fates of Fe3O4 and Fe3O4@SiO2 nanoparticles in human mesenchymal stem cells assessed by synchrotron radiation-based techniques","volume":"35","author":"Tian","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2026.115586_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.144200","article-title":"Stable Fe3O4 submicrospheres with SiO2 coating for heterogeneous Fenton-like reaction at alkaline condition","volume":"764","author":"Cai","year":"2021","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.colsurfb.2026.115586_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2024.112845","article-title":"Architecting ultra-thin SiO2 shell for high magnetic performance of Fe3O4 nanoparticles for biomedical applications","volume":"168","author":"Kheradmandfard","year":"2024","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.colsurfb.2026.115586_bib42","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.talanta.2016.03.081","article-title":"Synthesis and application of Fe3O4@SiO2@TiO2 for photocatalytic decomposition of organic matrix simultaneously with magnetic solid phase extraction of heavy metals prior to ICP-MS analysis","volume":"154","author":"Habila","year":"2016","journal-title":"Talanta"},{"key":"10.1016\/j.colsurfb.2026.115586_bib43","series-title":"Infrared and Raman Characteristic Group Frequencies: Tables and Charts","author":"Socrates","year":"2004"},{"key":"10.1016\/j.colsurfb.2026.115586_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.115049","article-title":"Autophagy-mediated ferroptosis involved in nickel-induced nephrotoxicity in the mice","volume":"259","author":"Yang","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115586_bib45","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41419-024-07135-1","article-title":"NINJ1 regulates ferroptosis via xCT antiporter interaction and coA modulation","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.colsurfb.2026.115586_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116512","article-title":"GPX4, ferroptosis, and diseases","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2214\/ajr.152.1.167","article-title":"Superparamagnetic iron oxide: pharmacokinetics and toxicity","volume":"152","author":"Weissleder","year":"1989","journal-title":"Ajr. Am. J. Roentgenol."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115586_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.addr.2010.09.003","article-title":"Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects","volume":"63","author":"Maruyama","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"27","key":"10.1016\/j.colsurfb.2026.115586_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201707003","article-title":"Silica-coated plasmonic metal nanoparticles in action","volume":"30","author":"Hanske","year":"2018","journal-title":"Adv. Mater."},{"issue":"51","key":"10.1016\/j.colsurfb.2026.115586_bib50","doi-asserted-by":"crossref","first-page":"16886","DOI":"10.1021\/acs.langmuir.9b03133","article-title":"Dumbbell-like silica coated gold nanorods and their plasmonic properties","volume":"35","author":"Wang","year":"2019","journal-title":"Langmuir"},{"issue":"36","key":"10.1016\/j.colsurfb.2026.115586_bib51","doi-asserted-by":"crossref","first-page":"26308","DOI":"10.1039\/D4RA05386A","article-title":"Advances in the preparation and biological applications of core@shell nanocrystals based on quantum dots and noble meta","volume":"14","author":"Wang","year":"2024","journal-title":"RSC Adv."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115586_bib52","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1021\/acsomega.7b01016","article-title":"Core\u2013shell nanoparticles as an efficient, sustained, and triggered drug-delivery system","volume":"2","author":"Deshpande","year":"2017","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115586_bib53","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3892\/ol.2020.11685","article-title":"Anlotinib as a molecular targeted therapy for tumors","volume":"20","author":"Gao","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.colsurfb.2026.115586_bib54","article-title":"Synergistic effects of anlotinib and DDP on breast cancer: targeting the VEGF\/JAK2\/STAT3 axis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.colsurfb.2026.115586_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/IJN.S566873","article-title":"Lipid-engineered small-sized metal-organic frameworks for targeted delivery of anlotinib in lung cancer treatment","volume":"21","author":"Fang","year":"2026","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib56","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/acsanm.4c05799","article-title":"Ammonium sulfate gradient-prepared anlotinib-loaded liposomes for potent tumor therapy with decreased side effect","volume":"8","author":"Sun","year":"2025","journal-title":"ACS Appl. Nano Mater."},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115586_bib57","doi-asserted-by":"crossref","first-page":"11355","DOI":"10.1021\/acsnano.8b06201","article-title":"Fenton-reaction-acceleratable magnetic nanoparticles for ferroptosis therapy of orthotopic brain tumors","volume":"12","author":"Shen","year":"2018","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115586_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"40","key":"10.1016\/j.colsurfb.2026.115586_bib59","doi-asserted-by":"crossref","first-page":"29039","DOI":"10.1039\/D4RA03837A","article-title":"Magnetic nanoparticles and possible synergies with cold atmospheric plasma for cancer treatment","volume":"14","author":"Dai","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.colsurfb.2026.115586_bib60","article-title":"Ferroptosis: mechanism, immunotherapy and role in ovarian cancer","volume":"15","author":"Guo","year":"2024","journal-title":"Front. Immunol."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526001748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526001748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:13:50Z","timestamp":1778775230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526001748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":60,"alternative-id":["S0927776526001748"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115586","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneous inorganic nanomedicine delivery system loaded with anlotinib for enhanced treatment of non-small cell lung cancer (NSCLC)","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115586","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115586"}}